FROM COMPLIANCE TO COMPETITIVE ADVANTAGE: WHAT CAA 2026 MEANS FOR YOUR PHARAMCY STRATEGY
Anu Dhamecha, PHARMD and Chris Antypas, PHARMD
THE NEXT WAVE OF PHARMACY REGULATION IS HERE—AND IT’S MORE COMPLICATED THAN A COMPLIANCE EXERCISE. The Consolidated Appropriations Act of 2026 (CAA 2026) represents a meaningful shift in how pharmacy benefit managers (PBMs) are evaluated, monitored, and held accountable. While (…)
There’s more to Read